Business Wire

Q4 Inc. Announces CFO Transition

Share

Q4 Inc. (TSX: QFOR), a leading capital markets communications platform, announced today that CFO Ryan Levenberg, will be resigning from his role on May 31, 2022. The Company is indebted to Mr. Levenberg for over 7 years of leadership which encompassed financings, acquisitions, and the Company’s recent IPO.

Q4 is pleased to further announce that Donna de Winter, Chief Operating Officer at Q4 since January 2019, with over 20 years of financial leadership across the technology sector, will assume the role of interim Chief Financial Officer. Prior to joining Q4, Ms. de Winter served as the CFO of Vision Critical (now Alida) and CFO of Varicent, where she led the company’s sale to IBM. Additionally, Ms. de Winter serves as a board member of Tealbook, a Toronto-based technology company.

“Ryan has been a tireless partner through the incredible growth and transformation Q4 has experienced over the last 7 years, culminating in our IPO,” said CEO and Founder Darrell Heaps. “We thank Ryan for his significant contributions and wish him the very best. We look forward to benefiting from Donna’s deep bench of experience as a financial leader of both private and publicly traded companies, as we pursue our mission to become the largest capital markets communications platform in the world.”

About Q4 Inc.

Q4 Inc. (TSX: QFOR) is a leading capital markets communications platform that is transforming the way publicly traded companies, investors and investment banks make decisions to efficiently discover, communicate and engage with each other. The Q4 end-to-end technology platform facilitates interactions across the capital markets through its IR website products, virtual events solutions, capital markets CRM, shareholder and market analytics tools. The firm is a trusted partner to more than 2,650 public companies globally including many of the most respected brands in the world. Q4 is based in Toronto, with offices in New York and London. Learn more at q4inc.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Investor Relations:
Sara Pearson, ir@q4inc.com

Media Inquiries:
Karen Greene, media@q4inc.com

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Exscientia Business Update for First Quarter 202225.5.2022 22:01:00 CEST | Press release

Exscientia plc (Nasdaq: EXAI) This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220525005906/en/ Recent advancements in the Company’s pipeline, collaborations, and operations, as well as financial results for the first quarter 2022, are summarised below. In addition, Exscientia will host a conference call Thursday, May 26 at 1:30 p.m. BST / 8:30 a.m. ET to provide an overview of the Company's precision medicine platform. "We started 2022 by commencing a groundbreaking collaboration with Sanofi to develop a pipeline of AI-designed medicines utilising the breadth of our end-to-end platform of AI-driven capabilities from target prioritisation, to drug engineering and patient selection. At this year's American Association of Cancer Research (AACR) Annual Meeting, we highlighted our advancements in this area, including how AI-enabled drug design can help create drug candidates for challenging targets in oncology. In addition, we sho

ArborXR Announces Strategic Collaboration with Qualcomm Technologies, Helping Companies Scale VR and AR Deployments25.5.2022 19:37:00 CEST | Press release

ArborXR announced today the company will work with Qualcomm Technologies, Inc. on an extended reality (XR) mobile device management (MDM) platform to make it easier for companies to scale virtual reality (VR) and augmented (AR) headset deployments. By working closely with original equipment manufacturer (OEM) partners and direct enterprise clients, ArborXR and Qualcomm Technologies have identified key problems that still exist in scaling a fleet of XR headsets. Companies today looking to deploy a fleet of VR or AR devices face many challenges enrolling and provisioning headsets, managing them remotely, installing apps and updates, and controlling the user experience. To solve these problems, ArborXR will provide device management software to Qualcomm Technologies’ XR customers and OEMs with large-scale deployments for use with Qualcomm Technologies’ cutting edge VR/AR hardware available. OEMs will be able to pre-install ArborXR, and ArborXR’s software will support new VR and AR referen

L&T Technology Services inaugurates Engineering R&D Centre in Poland to provide Embedded and Digital Solutions to Clients25.5.2022 19:05:00 CEST | Press release

L&T Technology Services Limited (BSE: 540115, NSE: LTTS), a global leading pure-play engineering services company, today inaugurated its Engineering, Research and Development (ER&D) centre in Krakow, Poland, which will cater to global customers, leveraging cutting edge technologies in the Automotive, Mobility and Hi-Tech domains. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220525005835/en/ Seen in the picture (from right to left): Jagyan Mishra, Delivery Head (Europe) at LTTS, Abhishek Sinha, Chief Operating Officer and Member of the Board at LTTS, Mr. Jerzy Muzyk, Deputy Mayor of the City of Krakow, Her Excellency Nagma Mohamed Mallick, Ambassador of India to the Republic of Poland, Mr. Lukasz Słoniowski, President of the Board at Investor Support Krakow and Rajkumar Ravindranathan, Chief Business Officer at LTTS, during the inauguration of the ER&D centre. (Photo: Business Wire) The state-of-the-art centre will mark its

E-LAND Innople Chooses Rimini Street Support Services for SAP S/4 HANA25.5.2022 18:00:00 CEST | Press release

Rimini Street, Inc. (Nasdaq: RMNI), a global provider of enterprise software products and services, the leading third-party support provider for Oracle and SAP software products, and a Salesforce partner, today announced that E-LAND Innople, an IT affiliate of the South Korean conglomerate E-Land Group, has chosen Rimini Street Support for SAP. The move has drastically cut E-LAND Innople’s annual maintenance costs and freed up budget to fuel new IT technology, digital transformation, and online expansion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220525005081/en/ E-LAND Innople Chooses Rimini Street Support Services for SAP S/4 HANA (Graphic: Business Wire) Rimini Street Support Increases Business Agility E-LAND Innople provides IT solutions across various industries including fashion, distribution, hotels, restaurants, and construction. The company is responsible for the IT operations of E-Land Group, including ERP man

Agendia Achieves Historic Milestone of Enrolling 10,000 Patients in FLEX, the Largest-Ever Prospective, Real-World-Evidence Trial for Patients With Early Stage Breast Cancer25.5.2022 17:39:00 CEST | Press release

Agendia, Inc., a commercial-stage company focused on improving outcomes for breast cancer patients worldwide by providing physicians and patients with next-generation diagnostic and information solutions to inform optimized treatment decision-making, today announced 10,000 patients have been successfully enrolled in the FLEX Registry. Agendia’s unique FLEX Registry is a real-world, large-scale, prospective, observational breast cancer study (NCT03053193) intended to enable the discovery of novel genomic profiles to improve precision in the management of breast cancer. The FLEX Registry’s groundbreaking approach to cancer research is accelerating impactful data generation with its patient-centric design and national network of participating sites, allowing its investigator-initiated sub-studies to produce critical results that drive science forward. Six posters based on data from FLEX will be presented at ASCO 2022, one of which will be a poster discussion session. “When we developed th